Adult acne affects up to one-third of 35-year-old Finnish women
Adult acne is more common than often assumed. According to research from the University of Oulu, around 31 per cent of 35-year-old Finnish women have acne on the […]
ADVERTISMENT
Adult acne is more common than often assumed. According to research from the University of Oulu, around 31 per cent of 35-year-old Finnish women have acne on the […]
A rigorous systematic review of the use of paracetamol (also known as acetaminophen) during pregnancy has found that the common painkiller does not increase the risk of specific […]
The EU drug watchdog, the European Medicines Agency (EMA), has launched a partnership with social media influencers to promote the safe use of GLP-1 receptor agonists. The #HealthNotHype […]
In a study led by researchers at Mass General Brigham, pregnant individuals who stopped taking popular weight loss GLP-1 medications before or early in their pregnancy tended to gain […]
Food companies are driving a global rise in ultra-processed food consumption that is damaging our health, and also preventing government action that could limit its harm, an international study reveals. […]
Clinical Pharmacy Congress North – Congress highlights A drug-eluting implant has been shown to reverse cystoid macular oedema and reduce the need for systemic treatment in 80% of […]
Orforglipron , an investigative and oral GLP-1 drug, appears to enable adults with obesity and Type 2 diabetes to achieve significantly more weight loss and improvement in blood […]
New research is uncovering how medications targeting the glucagon-like peptide-1 (GLP-1) system affect brain circuits involved in nausea, thirst, and pleasurable behaviors. These findings will be presented at […]
Young people in Scotland are experimenting with nicotine pouches and reporting adverse effects such as sickness and fainting, according to new research from the Scottish Centre for Social […]
The world’s largest collection of curated eye imaging and linked clinical data is expanding across the country, in an initiative led out of Moorfields Eye Hospital NHS Foundation […]
A major international study involving 23,000 people has found concerning evidence about the impact of a range of common, everyday medications on the treatment outcomes for patients with […]
A new observational study compared the risk for severe gastrointestinal adverse events across dulaglutide, semaglutide, and tirzepatide in patients with type 2 diabetes (T2D). The study found that […]
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare news and e-journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our email journals and publications.